Abstract
The activation of EphA2 receptor by its natural ligand EphrinA1 causes blood brain barrier dysfunction, and inactivation of EphA2 reduces BBB damage in ischemic stroke. Thus, EphA2 targeted antagonists may serve as neuroprotective agents. We engineered four mutants of EphrinA1, EM1, EM2, EM3 and EM4, respectively. The computational analysis showed that these four mutants were capable of interacting with EphA2. Their potential neuroprotective effects were examined in mouse focal ischemia/reperfusion (I/R) model. EM2 exhibited strong neuroprotective effects, including reduced brain infarct volume, neuronal apoptosis, cerebral edema, and improved neurological scores. The EM2-mediated protection was associated with a comparative decrease in BBB leakage, inflammatory infiltration, and higher expression levels of tight junction proteins, such as zonula occludens-1 and Occludin. I/R-induced high expression of Rho-associated protein kinase 2 (ROCK2) was down-regulated after EM2 treatment. Moreover, EM2 reduced agonist doxazosin-induced EphA2 phosphorylation and cells rounding in PC3 cells, indicating EphA2-antagonizing activity of EM2. These finding provided evidences of the neuroprotection of EphA2 antagonist and a novel approach for ...Continue Reading
References
Mar 5, 1992·Nature·R LüthyD Eisenberg
Aug 26, 1996·FEBS Letters·O NakagawaS Narumiya
Apr 5, 2001·Mechanisms of Development·C Naruse-NakajimaY Iwakura
May 7, 2002·Nature Cell Biology·Erik Sahai, Christopher J Marshall
Sep 28, 2002·The Journal of Biological Chemistry·Mitchell KoolpeElena B Pasquale
Dec 14, 2002·The International Journal of Biochemistry & Cell Biology·Juha-Pekka Himanen, Dimitar B Nikolov
Jun 5, 2003·Proteins·Rong ChenZhiping Weng
Oct 28, 2003·Proteins·Li LiZhiping Weng
Feb 25, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Neil A TurnerKaren E Porter
Jan 17, 2008·Journal of Cell Science·Wei Bin FangJin Chen
Apr 5, 2008·The Journal of Biological Chemistry·Wei Bin FangJin Chen
Sep 5, 2008·Thrombosis Research·Barden Chan, Vikas P Sukhatme
Sep 16, 2008·Neurobiology of Disease·Karin E Sandoval, Ken A Witt
Mar 7, 2009·Stroke; a Journal of Cerebral Circulation·Mathias GelderblomTim Magnus
May 20, 2009·Brain Research·Aysan DurukanTurgut Tatlisumak
Jun 16, 2009·EMBO Reports·Juha P HimanenDimitar B Nikolov
Nov 26, 2010·Experimental Neurology·Bin CaiZhi-Ying Wu
Jul 6, 2011·Microvascular Research·Na ZhouYu-Hua Chen
Jan 10, 2012·Brain Research·Kentaro DeguchiKoji Abe
Mar 1, 2012·The Journal of Biological Chemistry·Carla M Lema ToméWaldemar Debinski
Aug 24, 2012·PloS One·Aaron PettyBingcheng Wang
Sep 19, 2012·Cell Structure and Function·Michiro IizukaAkira Mizoguchi
Oct 2, 2012·The American Journal of Pathology·Mark G CoulthardAndrew W Boyd
Nov 22, 2012·Journal of Visualized Experiments : JoVE·Estelle RousseletNabil G Seidah
Nov 23, 2012·Biologie aujourd'hui·Vincent BérézowskiRoméo Cecchelli
Dec 25, 2012·Neuroscience Letters·Peng ZhangYinye Wang
Jan 12, 2013·PloS One·John ThundyilThiruma V Arumugam
Dec 7, 2013·Nature Medicine·Birgit ObermeierRichard M Ransohoff
Jan 1, 2014·Nature Reviews. Drug Discovery·Andrew W BoydMartin Lackmann
Mar 7, 2014·British Journal of Pharmacology·I Hassan-MohamedM Tognolini
Mar 29, 2014·PloS One·Yuanjun ZhuYinye Wang
Jun 19, 2014·Journal of Neuroscience Research·Kentaro DeguchiKoji Abe
Sep 2, 2014·Frontiers in Cellular Neuroscience·Rafael Andres Posada-DuqueGloria Patricia Cardona-Gomez
Jul 28, 2016·Canadian Journal of Physiology and Pharmacology·Mengyang ShuiYinye Wang
Nov 2, 2016·Current Protocols in Protein Science·Benjamin Webb, Andrej Sali
Citations
May 16, 2019·Neural Regeneration Research·Joon Ha ParkMoo-Ho Won
May 4, 2018·Histochemistry and Cell Biology·Sergey Shityakov, Carola Y Förster
Jun 4, 2020·Journal of Molecular Neuroscience : MN·Mostafa M Elgebaly
Jul 30, 2020·Neuroscience Letters·Yonglin ZhaoXing Wei
Feb 7, 2021·Brain Research Bulletin·Jingshu TangYing Peng
Mar 7, 2021·International Journal of Molecular Sciences·Ryszard PlutaStanisław J Czuczwar